Vascular refractory rejections due to activating anti-endothelial antibodies targeting angiotensin II type 1 receptor: Clinical presentation, incidence and outcomes.
AMERICAN JOURNAL OF TRANSPLANTATION（2005）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined